Key facts
- This page summarizes Robert C. Pallash's Form 4 filing for Livent Corp..
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 08 Jan 2024, 16:14.
Robert C. Pallash - 04 Jan 2024 Form 4 Insider Report for Livent Corp.
- Reporting relationship
- Director
- Issuer ticker
- N/A
- Reported as of
- 04 Jan 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 08 Jan 2024, 16:14:24 UTC
- Prior SEC filing
- 29 Nov 2023
- Next SEC filing
- 22 Jan 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Sara Ponessa, as attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Robert C. Pallash filed Form 4 for Livent Corp. on 08 Jan 2024.
Change
- Previous filing in this sequence was filed on 29 Nov 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
LTHM
transaction
Common Stock
Disposed to Issuer
- Transaction value
- Shares
- -31,565
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 04 Jan 2024
- Ownership
- Direct
- Footnotes
- F1
LTHM
transaction
Common Stock
Disposed to Issuer
- Transaction value
- Shares
- -48,412
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 04 Jan 2024
- Ownership
- Direct
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
Robert C. Pallash is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 2 footnotes
Footnote F1
Represents the conversion of each share of common stock of the Livent Corporation ("Livent"), par value $0.001 per share ("Livent Common Stock"), held by the reporting person as of January 4, 2024, into the right to receive a number of validly issued, fully paid and non-assessable ordinary shares of Arcadium Lithium plc ("Arcadium"), par value $1.00 each ("Arcadium Shares") equal to the Merger Exchange Ratio (as defined in the Transaction Agreement, dated as of May 10, 2023, by and between Livent, Allkem Limited ("Allkem"), Lightning-A Merger Sub, Inc. and Arcadium, providing for a combination of Livent and Allkem in a merger of equals transaction (the "Transaction Agreement")).
Footnote F2
Represents the cancellation and conversion of restricted stock units ("Livent RSUs") with respect to shares of Livent Common Stock, held by the reporting person as of January 4, 2024, into an amount of cash equal to (i) the number of shares of Livent Common Stock subject to such Livent RSUs immediately prior to the Effective Time of the merger (as defined in the Transaction Agreement), multiplied by (ii) the higher of (A) the first available closing price of the Merger Consideration (as defined in the Transaction Agreement) and (B) the closing price per share of Livent Common Stock as reported in the New York Stock Exchange, on the last trading day preceding the Closing Date of the merger (as defined in the Transaction Agreement).